Agilon Health, Inc. (NYSE:AGL) Receives $2.71 Average Target Price from Analysts

Shares of Agilon Health, Inc. (NYSE:AGL) have received a consensus recommendation of “Hold” from the seventeen analysts that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation and four have given a buy recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $2.7083.

AGL has been the subject of several recent research reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agilon Health in a research report on Wednesday, January 21st. BTIG Research reaffirmed a “neutral” rating on shares of Agilon Health in a report on Friday, December 12th. Zacks Research raised shares of Agilon Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, October 21st. Wells Fargo & Company cut their price objective on shares of Agilon Health from $1.50 to $1.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. Finally, Barclays decreased their price objective on shares of Agilon Health from $1.50 to $1.00 and set an “underweight” rating for the company in a research report on Thursday, November 6th.

Insiders Place Their Bets

In other Agilon Health news, Director John William Wulf purchased 81,000 shares of the stock in a transaction on Wednesday, November 12th. The shares were bought at an average price of $0.63 per share, for a total transaction of $51,030.00. Following the completion of the transaction, the director owned 365,857 shares of the company’s stock, valued at $230,489.91. This trade represents a 28.44% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders own 3.57% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in AGL. Wealthcare Advisory Partners LLC purchased a new stake in Agilon Health in the 3rd quarter worth $26,000. Arrowpoint Investment Partners Singapore Pte. Ltd. acquired a new position in shares of Agilon Health during the 2nd quarter worth about $31,000. Krilogy Financial LLC acquired a new position in shares of Agilon Health during the 4th quarter worth about $34,000. CIBC Bancorp USA Inc. purchased a new position in Agilon Health in the 3rd quarter valued at about $34,000. Finally, Merit Financial Group LLC acquired a new stake in Agilon Health in the 4th quarter worth about $35,000.

Agilon Health Price Performance

Shares of Agilon Health stock opened at $0.83 on Thursday. The stock has a market cap of $344.10 million, a PE ratio of -1.11 and a beta of 0.05. The firm has a fifty day moving average price of $0.78 and a 200 day moving average price of $1.00. Agilon Health has a 1 year low of $0.51 and a 1 year high of $6.08.

Agilon Health (NYSE:AGL) last announced its quarterly earnings results on Tuesday, November 4th. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.09). The company had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.43 billion. Agilon Health had a negative return on equity of 75.92% and a negative net margin of 5.24%. As a group, equities analysts expect that Agilon Health will post -0.59 EPS for the current year.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.